What is InvoSurg?
InvoSurg Inc. operates as a specialized medical device distribution entity, leveraging over a decade of industry experience to serve the cardiac surgery and extracorporeal life support markets. The company distinguishes itself through a high-touch, education-centric service model, where more than 60% of its field personnel possess deep clinical expertise, particularly in cardiac perfusion. By acting as a critical bridge between innovative technology manufacturers and clinical practitioners, InvoSurg addresses complex medical challenges through a curated portfolio of best-in-class solutions. Its market position is defined by this unique synthesis of technical distribution and clinical training, ensuring that advanced life-support technologies are effectively integrated into hospital workflows.
How much funding has InvoSurg raised?
InvoSurg has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in InvoSurg
PPP
Public-Private Partnership
What's next for InvoSurg?
With the recent influx of capital, InvoSurg is poised to accelerate its strategic growth initiatives. The company is expected to deepen its partnerships with industry leaders, potentially expanding its product pipeline to address emerging needs in extracorporeal life support. Furthermore, the investment provides the necessary liquidity to scale its clinical training infrastructure, a core competitive advantage that differentiates the firm from traditional distributors. As the company navigates this late-stage growth phase, the focus will likely shift toward optimizing supply chain efficiencies and broadening its geographic reach, ensuring that its specialized cardiac solutions remain accessible to a wider network of healthcare providers and surgical centers.
See full InvoSurg company page
